Tickerplace logo

Tickerplace

Spyre Therapeutics, Inc. (SYRE): calculated intrinsic value vs market price

Calculated intrinsic value vs market price

Spyre Therapeutics, Inc. (SYRE) current market price $88.50; calculated gap vs modeled fair value is 7643.92%. The dollar intrinsic value estimate is available with Tickerplace Pro.

  • Fair value gap (live) 7643.92% (from live valuation API)
  • Confidence (live) 8.5/10 (Large gap)

Confidence score is based on the magnitude of the gap vs the modeled estimate.

Fair value estimate

Unlock fair value

Current price

$88.50

Explore Our Valuation Calculators

Intrinsic Value Calculator (DCF)ROE CalculatorStock Valuation Calculator

How to read the price vs calculated fair value gap for Spyre Therapeutics, Inc.

Intrinsic value work for Spyre Therapeutics, Inc. anchors fair value on owner earnings and balance-sheet capacity, then places the current quote next to that estimate.

Versus historical valuation bands, SYRE can sit toward the lower or upper end of where this business has traded when profitability and growth were comparable — useful context before reading any single headline multiple.

Sector peers and macro rates still deserve a sanity check on the company page. The percentage gap on this snapshot is a model output, not a recommendation.

Key metrics

P/E ratio
42.1x
Revenue growth (TTM y/y)
3%
Profit margin
27.2%
Fair value (model)
Unlock

Next steps

Frequently asked questions — SYRE

What is SYRE’s calculated intrinsic value vs its market price?

Spyre Therapeutics, Inc. (SYRE) current market price is $88.50, a calculated difference of 7643.9% versus modeled fair value. Tickerplace Pro unlocks the dollar intrinsic value estimate. This is a model output, not a recommendation.

What is Spyre Therapeutics, Inc.'s intrinsic value?

Intrinsic value is an estimate of what SYRE shares may be worth based on fundamentals rather than today's price alone. See the valuation snapshot on this page for the latest model output. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Spyre Therapeutics, Inc.'s intrinsic value calculated?

Tickerplace calculates SYRE's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to show the calculated gap.

How should I read SYRE’s fair value gap?

SYRE’s calculated gap versus modeled fair value is 7643.9% at a market price of $88.50. A gap is a calculated difference between price and the model estimate, not a buy or sell conclusion. Confirm with ratios and financials on the company profile.